Pluristem and Thermo Fisher Look to Plug Gaps in Cell Therapy ManufactureAllbiopro2018-07-21T15:00:42+09:007월 21st, 2018|
Patient death prompts FDA hold on Mersana’s lead cancer ADCAllbiopro2018-07-21T14:59:42+09:007월 21st, 2018|
Rumor Alert: Merck KGaA to Buy Madrigal and Roche to Acquire Tesaro?Allbiopro2018-07-21T14:58:48+09:007월 21st, 2018|
PTC Therapeutics to Buy Agilis Biotherapeutics in Deal that Could Exceed $945 MillionAllbiopro2018-07-21T14:57:52+09:007월 21st, 2018|
Roche, PureTech team up to develop oral antisense oligonucleotidesAllbiopro2018-07-21T14:56:57+09:007월 21st, 2018|
Insilico and A2A launch new Duchenne-focused AI drug companyAllbiopro2018-07-21T14:56:01+09:007월 21st, 2018|
‘Dramatic’ Gene Therapy Demand Drives Viral Vector DelaysAllbiopro2018-07-21T14:55:05+09:007월 21st, 2018|
PTC inks $200M Agilis takeover to snag late-phase gene therapyAllbiopro2018-07-21T14:54:09+09:007월 21st, 2018|
Spooked AbbVie investors are selling off shares—but do they need to be?Allbiopro2018-07-21T14:53:14+09:007월 21st, 2018|
FDA, Trump Administration Explore Importing Foreign Drugs Under Narrow ScopeAllbiopro2018-07-21T14:52:15+09:007월 21st, 2018|
Riding on patent office win, Novartis takes Gilenya generics fight to courtAllbiopro2018-07-21T14:51:20+09:007월 21st, 2018|
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be usedAllbiopro2018-07-21T14:50:24+09:007월 21st, 2018|
Servier picks Shire executive to run U.S. business being built out of deal for Shire’s oncology unitAllbiopro2018-07-21T14:49:33+09:007월 21st, 2018|
Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze: analystsAllbiopro2018-07-21T14:49:03+09:007월 21st, 2018|
Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a YearAllbiopro2018-07-21T14:48:38+09:007월 21st, 2018|
Shuwen Biotech’s Clinical Lab Successfully Passes Biyearly College of American Pathologists AuditAllbiopro2018-07-20T10:31:04+09:007월 20th, 2018|
Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid TumorsAllbiopro2018-07-20T10:30:39+09:007월 20th, 2018|
